The presence of CD24+CD133+ progenitor cells in urine suggests their potential use for modelling genetic disorders and for personalized therapeutic approaches, avoiding both the risk associated with isolation from biopsies and the alteration in cell features caused by the immortalization process [26] (pp. This evidence concerns the gene CD24 and hereditary disease.